Have a personal or library account? Click to login
Protective/restorative role of the adipose tissue-derived mesenchymal stem cells on the radioiodine-induced salivary gland damage in rats Cover

Protective/restorative role of the adipose tissue-derived mesenchymal stem cells on the radioiodine-induced salivary gland damage in rats

Radiology and Oncology
Volume 51 (2017): Issue 3 (September 2017)
By: Güleser Saylam,  Ömer Bayır,  Salih Sinan Gültekin,  Ferda Alparslan Pınarlı,  Ünsal Han,  Mehmet Hakan Korkmaz,  Mehmet Eser Sancaktar,  İlkan Tatar,  Mustafa Fevzi Sargon and  Emel Çadallı Tatar  
Open Access
|Jun 2017

Figures & Tables

Figure 1

Histological photographs of salivary gland tissue samples. Pictures on the upper horizontal line show control groups at 1st month evaluation (A; haematoxylin and eosin (H&E)×40), and at 6th month evaluation in different magnifications (B; H&E×200, C; H&E×400). Pictures on the second horizontal line (D to F; ×200 Leica DM 1000) shows the localization of BrdU(+) Adipose Derived Mesenchimal Stem Cells (ADMSC) in the salivary gland (brown stained cells) at 1st month after its intraperitoneal injection in different magnifications. Radioiodine-induced damage in Group 1 is seen in pictures on the third horizontal line (G to I; H&E×400, H&E×400 and H&E×100). Massive vacuolization, necrosis (black arrow) and edema were shown in G minimal vacuolization (black arrow) and periductal fibrosis (black star) in H and lenfosit infiltration (black arrow) in I. Pictures on the lower horizontal line (J to L H&E×400, H&E×200 and H&E×40) indicates the improvements in the histological findings (including vacuolization, fibrosis and edema: black arrow; nearly normal mucous acini, black star; nearly normal ductal system) at 6th month evaluation after the late ADMSC administration in Group 6.
Histological photographs of salivary gland tissue samples. Pictures on the upper horizontal line show control groups at 1st month evaluation (A; haematoxylin and eosin (H&E)×40), and at 6th month evaluation in different magnifications (B; H&E×200, C; H&E×400). Pictures on the second horizontal line (D to F; ×200 Leica DM 1000) shows the localization of BrdU(+) Adipose Derived Mesenchimal Stem Cells (ADMSC) in the salivary gland (brown stained cells) at 1st month after its intraperitoneal injection in different magnifications. Radioiodine-induced damage in Group 1 is seen in pictures on the third horizontal line (G to I; H&E×400, H&E×400 and H&E×100). Massive vacuolization, necrosis (black arrow) and edema were shown in G minimal vacuolization (black arrow) and periductal fibrosis (black star) in H and lenfosit infiltration (black arrow) in I. Pictures on the lower horizontal line (J to L H&E×400, H&E×200 and H&E×40) indicates the improvements in the histological findings (including vacuolization, fibrosis and edema: black arrow; nearly normal mucous acini, black star; nearly normal ductal system) at 6th month evaluation after the late ADMSC administration in Group 6.

Figure 2

The figure (magnification × 5000) demonstrates the findings of electron microscopy at months 1 and 6. (A and B). Normal salivary gland samples of the control group. A and D. Intracellular vacuoles and intercellular edema related to radioiodine in Group 1. E and F. We observed intracellular vacuoles, intercellular edema, nucleus of fibroblast and collagen fibers (fibrosis) at 1st month evaluation in the treatment groups (Groups 5 and 6); G to J. Improvement in cellular damage at 6th month in the stem cell-administered groups (Groups 5 and 6). On the images; c: collagen fibers; e: intercellular edema; f: nucleus of fibroblast; n: nucleus, p: dilated perinuclear cistern; v: intracellular vacuoles.
The figure (magnification × 5000) demonstrates the findings of electron microscopy at months 1 and 6. (A and B). Normal salivary gland samples of the control group. A and D. Intracellular vacuoles and intercellular edema related to radioiodine in Group 1. E and F. We observed intracellular vacuoles, intercellular edema, nucleus of fibroblast and collagen fibers (fibrosis) at 1st month evaluation in the treatment groups (Groups 5 and 6); G to J. Improvement in cellular damage at 6th month in the stem cell-administered groups (Groups 5 and 6). On the images; c: collagen fibers; e: intercellular edema; f: nucleus of fibroblast; n: nucleus, p: dilated perinuclear cistern; v: intracellular vacuoles.

Figure 3

The figure represents functional data obtained from the time-activity curves of rats. A time-activity curve generated from dynamic scintigraphic data depicts the functional changing in activity of rat salivary glands over time. A baseline study (left side; A, C, E, G) and a six-month follow-up study (right side; B, D, F, H) on the rats was performed by 99mTc-pertecnetate salivary gland scintigraphy (2 mCi, 120 frames, 20 second per frame, 40 min). The functional differences between baseline and post-treatment status can be easily seen, and compared by time-activity curves. Definitions on a time-activity curve in this figure are as follows: x axis; examination time (minutes), y axis; count data (counts/second), purple line; left salivary gland activity curve, blue line; right salivary gland activity curve and red line; background tissue activity curve. (A and B). A significant deterioration in function over time with decreased gland uptake and secretion capability with only radioiodine administration (Group 1) is seen. (C to H). Radioiodine plus concomitant amifostine (Group 4; C and D), radioiodine plus concomitant (Groups 5; E and F) and after 48 h (Group 6; G and H) adipose tissue-derived mesenchymal stem cells administrations show mild to moderate deteriorations in function over time in terms of slope of the curve and secretion capability of the gland.
The figure represents functional data obtained from the time-activity curves of rats. A time-activity curve generated from dynamic scintigraphic data depicts the functional changing in activity of rat salivary glands over time. A baseline study (left side; A, C, E, G) and a six-month follow-up study (right side; B, D, F, H) on the rats was performed by 99mTc-pertecnetate salivary gland scintigraphy (2 mCi, 120 frames, 20 second per frame, 40 min). The functional differences between baseline and post-treatment status can be easily seen, and compared by time-activity curves. Definitions on a time-activity curve in this figure are as follows: x axis; examination time (minutes), y axis; count data (counts/second), purple line; left salivary gland activity curve, blue line; right salivary gland activity curve and red line; background tissue activity curve. (A and B). A significant deterioration in function over time with decreased gland uptake and secretion capability with only radioiodine administration (Group 1) is seen. (C to H). Radioiodine plus concomitant amifostine (Group 4; C and D), radioiodine plus concomitant (Groups 5; E and F) and after 48 h (Group 6; G and H) adipose tissue-derived mesenchymal stem cells administrations show mild to moderate deteriorations in function over time in terms of slope of the curve and secretion capability of the gland.

Histological findings in the salivary glands of the rats_ Mean values of salivary gland damage parameters are given_ *Details of groups are given below the table

Site ofdamageInvestigatedparametersControlGroup 1Group 2Group 3Group 4Group 5Group 6
1st m6th mp1st m6th mp1st m6th mp1st m6th mp1st m6th mp1st m6th mp1st m6th mp
Edema3.675.5ns67.17ns5.677.670.0555.5ns4.3370.024.334.83ns5.6730.02
Acinar epithelial cell damageVacuolization4.333.5ns6.676.33ns570.044.674.17ns45.33ns53.67ns5.3320.02
Peri acinar inflammation00ns0.670.17ns1.330.17ns0.670.17ns00.17ns00.17ns200.02
Necrosis0.672.33ns01.330.0420.5ns1.671ns01ns0.330ns0.670.17ns
Ductal system damageEctasia33.33ns6.335.83ns4.336ns3.672.5ns2.674.670.013.673.5ns3.330.830.04
Periductal fibrosis00ns13.330.022.333.33ns10.33ns02.330.0201.330.0100.67ns
Interstitial space damagePeriduktal sclerosis00.17ns02.170.021.331.83ns100.0300.33ns00.67ns00ns
Periductal mucus leakage10.5ns11ns0.671.33ns1.331ns0.330.83ns0.330.33ns30.50.02
Vascular system damageSclerosis00.17ns14.50.011.673.5ns1.330.5ns0.671.17ns01.170.011.670.5ns
Total12.6715.5ns22.6731.830.0224.3331.33ns20.3415.170.051222.830.0213.6615.67ns21.677.670.02

The mean values (the counts from left and right salivary glands) of the Smax, Tmax/Tmin and G/BGmax, and their statistical significance_ Baseline and follow-up salivary gland scintigraphies were performed on the subjects who had single treatment (Group 1; radioiodine, Group 2; adipose tissue-derived mesenchymal stem cells, Group 3; amifostine) and combined treatments (Group 4; radioiodine plus amifostine, Group 5; radioiodine plus adipose tissue-derived mesenchymal stem cells concomitant, Group 6; radioiodine plus adipose tissue-derived mesenchymal stem cells after 48 h)

GroupsSmax (%)Tmax/TminG/BGmax
Baseline1st m6th mpBaseline1st m6th mpBaseline1st m6th mp
Group 134.8029.5819.720.040.070.080.140.051.631.381.300.04
Group 234.7434.3134.62ns0.060.060.07ns1.591.571.58ns
Group 334.7234.3833.83ns0.080.080.09ns1.591.561.57ns
Group 433.0730.3028.880.040.080.080.09ns1.571.491.440.04
Group 533.5132.9128.890.040.080.080.09ns1.581.521.490.04
Group 635.5531.6026.070.040.070.070.09ns1.601.511.360.04
pns0.010.01 nsns0.03 ns0.010.01
DOI: https://doi.org/10.1515/raon-2017-0022 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 307 - 316
Submitted on: Dec 21, 2016
|
Accepted on: Apr 7, 2017
|
Published on: Jun 14, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
salivary gland,
radioiodine treatment,
radiation damage,
radiation protection,
stem cell transplantation,
adipose tissue-derived mesenchymal stem cells
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2017 Güleser Saylam, Ömer Bayır, Salih Sinan Gültekin, Ferda Alparslan Pınarlı, Ünsal Han, Mehmet Hakan Korkmaz, Mehmet Eser Sancaktar, İlkan Tatar, Mustafa Fevzi Sargon, Emel Çadallı Tatar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 51 (2017): Issue 3 (September 2017)Next article